Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E N Fish

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Biochemical and Biophysical Research Communications|June 9, 1997
Interaction of p59fyn with interferon-activated Jak kinasesS Uddin, D A Sher, Y Alsayed, et al.
The Journal of Biological Chemistry|October 9, 1999
Activation of the p38 mitogen-activated protein kinase by type I interferonsS Uddin, B Majchrzak, J Woodson, et al.
Oncogene|July 4, 2017
Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastomaA D Arslan, A Sassano, D Saleiro, et al.
The Journal of Biological Chemistry|July 6, 2000
The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteinsS Uddin, F Lekmine, N Sharma, et al.
Blood|November 5, 1997
The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-alpha receptorsS Uddin, E N Fish, D Sher, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 6, 2007
Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseasesF G Mastronardi, H Tsui, S Winer, et al.
British Journal of Haematology|February 13, 2001
Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cellsI M Grumbach, I A Mayer, S Uddin, et al.
The Journal of Biological Chemistry|May 17, 2001
The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cellsI A Mayer, A Verma, I M Grumbach, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Biochemical and Biophysical Research Communications|June 9, 1997
Interaction of p59fyn with interferon-activated Jak kinasesS Uddin, D A Sher, Y Alsayed, et al.
The Journal of Biological Chemistry|October 9, 1999
Activation of the p38 mitogen-activated protein kinase by type I interferonsS Uddin, B Majchrzak, J Woodson, et al.
Oncogene|July 4, 2017
Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastomaA D Arslan, A Sassano, D Saleiro, et al.
The Journal of Biological Chemistry|July 6, 2000
The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteinsS Uddin, F Lekmine, N Sharma, et al.
Blood|November 5, 1997
The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-alpha receptorsS Uddin, E N Fish, D Sher, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 6, 2007
Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseasesF G Mastronardi, H Tsui, S Winer, et al.
British Journal of Haematology|February 13, 2001
Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cellsI M Grumbach, I A Mayer, S Uddin, et al.
The Journal of Biological Chemistry|May 17, 2001
The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cellsI A Mayer, A Verma, I M Grumbach, et al.
Pageof 6